Arthur G, Page L, Mock T, Choy P C
Biochem J. 1986 Jun 1;236(2):475-80. doi: 10.1042/bj2360475.
The hydrolysis of the alkenyl bonds of plasmenylcholine and plasmenylethanolamine by plasmalogenase, followed by hydrolysis of the resultant lysophospholipid by lysophospholipase, has been postulated as the major pathway for the catabolism of these plasmalogens. However, the postulation was based solely on the presence of plasmalogenase activity towards plasmenylethanolamine and plasmenylcholine in the brain. In this study we have demonstrated the absence of plasmalogenase activity for plasmenylcholine in the guinea pig heart under a wide range of experimental conditions. Plasmenylcholine was hydrolysed by phospolipase A2 activities in cardiac microsomal, mitochondrial and cytosolic fractions. Phospholipase A2 activities in these fractions had an alkaline pH optimum and were enhanced by Ca2+. The enzymes also displayed high specificity for plasmenylcholine with linoleoyl or oleoyl at the C-2 position. Lysoplasmalogenase activity for lysoplasmenycholine was also detected and characterized in the microsomal and mitochondrial fractions. Since the cardiac plasmalogenase is only active towards plasmenylethanolamine but not plasmenylcholine, the catabolism of these two plasmalogens must be different from each other. We postulate that the major pathway for the catabolism of plasmenycholine involves the hydrolysis of the C-2 fatty acid by phospholipase A2, and hydrolysis of the vinyl ether group of the resultant lysoplasmenylcholine by lysoplasmalogenase.
有人提出,缩醛磷脂酶水解缩醛磷脂酰胆碱和缩醛磷脂酰乙醇胺的烯基键,随后溶血磷脂酶水解生成的溶血磷脂,是这些缩醛磷脂分解代谢的主要途径。然而,这一假设仅仅是基于大脑中存在对缩醛磷脂酰乙醇胺和缩醛磷脂酰胆碱有活性的缩醛磷脂酶。在本研究中,我们已证实在广泛的实验条件下,豚鼠心脏中不存在针对缩醛磷脂酰胆碱的缩醛磷脂酶活性。心脏微粒体、线粒体和胞质部分中的磷脂酶A2活性可水解缩醛磷脂酰胆碱。这些部分中的磷脂酶A2活性在碱性pH值时最适宜,且Ca2+可增强其活性。这些酶对C-2位带有亚油酰基或油酰基的缩醛磷脂酰胆碱也表现出高特异性。在微粒体和线粒体部分中也检测并鉴定了针对溶血缩醛磷脂酰胆碱的溶血缩醛磷脂酶活性。由于心脏缩醛磷脂酶仅对缩醛磷脂酰乙醇胺有活性,而对缩醛磷脂酰胆碱无活性,因此这两种缩醛磷脂的分解代谢必定互不相同。我们推测,缩醛磷脂酰胆碱分解代谢的主要途径包括磷脂酶A2水解C-2脂肪酸,以及溶血缩醛磷脂酶水解生成的溶血缩醛磷脂酰胆碱的乙烯醚基团。